Rescue of peripheral and CNS axon defects in mice lacking NMNAT2

Jonathan Gilley, Robert Adalbert, Gang Yu, Michael P. Coleman

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

NMNAT2 is an NAD +-synthesizing enzyme with an essential axon maintenance role in primary culture neurons. We have generated an Nmnat2 gene trap mouse to examine the role of NMNAT2 in vivo. Homozygotes die perinatally with a severe peripheral nerve/axon defect and truncated axons in the optic nerve and other CNS regions. The cause appears to be limited axon extension, rather than dying-back degeneration of existing axons, which was previously proposed for the NMNAT2-deficient Bladmutant mouse. Neurite outgrowth in both PNS and CNS neuronal cultures consistently stalls at 1-2 mm, similar to the length of truncated axons in the embryos. Crucially, this suggests an essential role for NMNAT2 during axon growth. In addition, we show that the Wallerian degeneration slow protein (Wld), a more stable, aberrant NMNAT that can substitute the axon maintenance function of NMNAT2 in primary cultures, can also correct developmental defects associated with NMNAT2 deficiency. This is dose-dependent, with extension of life span to at least 3 months by homozygous levels of Wld the most obvious manifestation. Finally, we propose that endogenous mechanisms also compensate for otherwise limiting levels of NMNAT2. This could explain our finding that conditional silencing of a single Nmnat2 allele triggers substantial degeneration of established neurites, whereas similar, or greater, reduction of NMNAT2 in constitutively depleted neurons is compatible with normal axon growth and survival. A requirement for NMNAT2 for both axon growth and maintenance suggests that reduced levels could impair axon regeneration as well as axon survival in aging and disease.

Original languageEnglish (US)
Pages (from-to)13410-13424
Number of pages15
JournalJournal of Neuroscience
Volume33
Issue number33
DOIs
StatePublished - 2013

Fingerprint

Axons
Maintenance
Growth
Wallerian Degeneration
Neurons
Homozygote
Neurites
Optic Nerve
Life Expectancy
Peripheral Nerves
NAD
Regeneration
Embryonic Structures
Alleles

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rescue of peripheral and CNS axon defects in mice lacking NMNAT2. / Gilley, Jonathan; Adalbert, Robert; Yu, Gang; Coleman, Michael P.

In: Journal of Neuroscience, Vol. 33, No. 33, 2013, p. 13410-13424.

Research output: Contribution to journalArticle

Gilley, Jonathan ; Adalbert, Robert ; Yu, Gang ; Coleman, Michael P. / Rescue of peripheral and CNS axon defects in mice lacking NMNAT2. In: Journal of Neuroscience. 2013 ; Vol. 33, No. 33. pp. 13410-13424.
@article{2edc3ac5e9c94349b5ac185468298626,
title = "Rescue of peripheral and CNS axon defects in mice lacking NMNAT2",
abstract = "NMNAT2 is an NAD +-synthesizing enzyme with an essential axon maintenance role in primary culture neurons. We have generated an Nmnat2 gene trap mouse to examine the role of NMNAT2 in vivo. Homozygotes die perinatally with a severe peripheral nerve/axon defect and truncated axons in the optic nerve and other CNS regions. The cause appears to be limited axon extension, rather than dying-back degeneration of existing axons, which was previously proposed for the NMNAT2-deficient Bladmutant mouse. Neurite outgrowth in both PNS and CNS neuronal cultures consistently stalls at 1-2 mm, similar to the length of truncated axons in the embryos. Crucially, this suggests an essential role for NMNAT2 during axon growth. In addition, we show that the Wallerian degeneration slow protein (Wld), a more stable, aberrant NMNAT that can substitute the axon maintenance function of NMNAT2 in primary cultures, can also correct developmental defects associated with NMNAT2 deficiency. This is dose-dependent, with extension of life span to at least 3 months by homozygous levels of Wld the most obvious manifestation. Finally, we propose that endogenous mechanisms also compensate for otherwise limiting levels of NMNAT2. This could explain our finding that conditional silencing of a single Nmnat2 allele triggers substantial degeneration of established neurites, whereas similar, or greater, reduction of NMNAT2 in constitutively depleted neurons is compatible with normal axon growth and survival. A requirement for NMNAT2 for both axon growth and maintenance suggests that reduced levels could impair axon regeneration as well as axon survival in aging and disease.",
author = "Jonathan Gilley and Robert Adalbert and Gang Yu and Coleman, {Michael P.}",
year = "2013",
doi = "10.1523/JNEUROSCI.1534-13.2013",
language = "English (US)",
volume = "33",
pages = "13410--13424",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "33",

}

TY - JOUR

T1 - Rescue of peripheral and CNS axon defects in mice lacking NMNAT2

AU - Gilley, Jonathan

AU - Adalbert, Robert

AU - Yu, Gang

AU - Coleman, Michael P.

PY - 2013

Y1 - 2013

N2 - NMNAT2 is an NAD +-synthesizing enzyme with an essential axon maintenance role in primary culture neurons. We have generated an Nmnat2 gene trap mouse to examine the role of NMNAT2 in vivo. Homozygotes die perinatally with a severe peripheral nerve/axon defect and truncated axons in the optic nerve and other CNS regions. The cause appears to be limited axon extension, rather than dying-back degeneration of existing axons, which was previously proposed for the NMNAT2-deficient Bladmutant mouse. Neurite outgrowth in both PNS and CNS neuronal cultures consistently stalls at 1-2 mm, similar to the length of truncated axons in the embryos. Crucially, this suggests an essential role for NMNAT2 during axon growth. In addition, we show that the Wallerian degeneration slow protein (Wld), a more stable, aberrant NMNAT that can substitute the axon maintenance function of NMNAT2 in primary cultures, can also correct developmental defects associated with NMNAT2 deficiency. This is dose-dependent, with extension of life span to at least 3 months by homozygous levels of Wld the most obvious manifestation. Finally, we propose that endogenous mechanisms also compensate for otherwise limiting levels of NMNAT2. This could explain our finding that conditional silencing of a single Nmnat2 allele triggers substantial degeneration of established neurites, whereas similar, or greater, reduction of NMNAT2 in constitutively depleted neurons is compatible with normal axon growth and survival. A requirement for NMNAT2 for both axon growth and maintenance suggests that reduced levels could impair axon regeneration as well as axon survival in aging and disease.

AB - NMNAT2 is an NAD +-synthesizing enzyme with an essential axon maintenance role in primary culture neurons. We have generated an Nmnat2 gene trap mouse to examine the role of NMNAT2 in vivo. Homozygotes die perinatally with a severe peripheral nerve/axon defect and truncated axons in the optic nerve and other CNS regions. The cause appears to be limited axon extension, rather than dying-back degeneration of existing axons, which was previously proposed for the NMNAT2-deficient Bladmutant mouse. Neurite outgrowth in both PNS and CNS neuronal cultures consistently stalls at 1-2 mm, similar to the length of truncated axons in the embryos. Crucially, this suggests an essential role for NMNAT2 during axon growth. In addition, we show that the Wallerian degeneration slow protein (Wld), a more stable, aberrant NMNAT that can substitute the axon maintenance function of NMNAT2 in primary cultures, can also correct developmental defects associated with NMNAT2 deficiency. This is dose-dependent, with extension of life span to at least 3 months by homozygous levels of Wld the most obvious manifestation. Finally, we propose that endogenous mechanisms also compensate for otherwise limiting levels of NMNAT2. This could explain our finding that conditional silencing of a single Nmnat2 allele triggers substantial degeneration of established neurites, whereas similar, or greater, reduction of NMNAT2 in constitutively depleted neurons is compatible with normal axon growth and survival. A requirement for NMNAT2 for both axon growth and maintenance suggests that reduced levels could impair axon regeneration as well as axon survival in aging and disease.

UR - http://www.scopus.com/inward/record.url?scp=84881500396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881500396&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1534-13.2013

DO - 10.1523/JNEUROSCI.1534-13.2013

M3 - Article

C2 - 23946398

AN - SCOPUS:84881500396

VL - 33

SP - 13410

EP - 13424

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 33

ER -